Biocon — Fact Sheet (June 2021)

4 slides from Biocon's fact sheet, June 2021

Slide 1: Biocon Group Fact Sheet June 2021
5 BIOCON GROUP FACT SHEET June - 2021
Slide 2: Biocon Limited (Consolidated) Profit & Loss Statement Q1 FY22 vs Q1 FY21
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Particulars Q1'FY 22 Q1'FY 21 Variance % INCOME Generics 486 621 -22% Biosimilars 758 692 10% Novel Biologics 11 - 100% Research services 595 422 41% Inter-segment (89) (41) 119% Revenue from operations # 1,761 1,694 4% Other income
Slide 3: Biocon Limited (Consolidated) Profit & Loss Statement Q1 FY22 vs Q4 FY21
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Particulars Q1' FY 22 Q4' FY 21 Variance % INCOME Generics 486 570 -15% Biosimilars 758 664 14% Novel Biologics 11 11 5% Research services 595 659 -10% Inter-segment (89) (61) 46% Revenue from operations # 1,761 1,842 -4% Other incom
Slide 4: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs. Crores) Particulars June 30, 2021 March 31, 2021 ASSETS Non-current assets (a) Property, plant and equipment 5,607 5,557 (b) Capital work-in-progress 2,452 2,254 (c) Right-of-use assets 160 153 (d) Goodwill 26 26 (e) Other intangible assets 643 627 (f